Device type · LWR
Heart-Valve, Non-Allograft Tissue
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LWR
Cardiovascular
Device class
Class III
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
2,132
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Heart-Valve, Non-Allograft Tissue
- Product code
- LWR
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for LWR
Latest FDA decisions
- TRIFORMIS RESILIA Tricuspid ValvePMA supplement
P150048-S092 · Decided Oct 27, 2025 · 180 days after receipt · Panel Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
- Edwards Pericardial Mitral Bioprosthesis, Model 11000MPMA supplement
P150048-S012 · Decided Aug 9, 2018 · 251 days after receipt · Panel Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
P170006 · Decided Jul 31, 2017 · 179 days after receipt
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
P150048 · Decided Jun 29, 2017 · 549 days after receipt
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
P150036 · Decided Aug 12, 2016 · 304 days after receipt
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
P150011 · Decided Jan 8, 2016 · 312 days after receipt
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
Reports received
2,132
Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.
Malfunction reports
214
10% of reports
Injury reports
1,832
86% of reports
Death reports
84
3.9% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 8 | 133 | 10 | 0 |
| Jan 24 | 10 | 103 | 4 | 0 |
| Feb 24 | 7 | 104 | 7 | 0 |
| Mar 24 | 8 | 133 | 8 | 0 |
| Apr 24 | 24 | 140 | 6 | 0 |
| May 24 | 11 | 141 | 10 | 0 |
| Jun 24 | 13 | 133 | 7 | 0 |
| Jul 24 | 12 | 136 | 6 | 0 |
| Aug 24 | 13 | 128 | 7 | 0 |
| Sep 24 | 12 | 133 | 5 | 0 |
| Oct 24 | 13 | 176 | 17 | 0 |
| Nov 24 | 41 | 109 | 5 | 0 |
| Dec 24 | 16 | 127 | 4 | 0 |
| Jan 25 | 28 | 118 | 3 | 0 |
| Feb 25 | 11 | 121 | 4 | 0 |
| Mar 25 | 8 | 161 | 8 | 0 |
| Apr 25 | 19 | 124 | 5 | 0 |
| May 25 | 11 | 120 | 5 | 0 |
| Jun 25 | 16 | 137 | 6 | 0 |
| Jul 25 | 9 | 138 | 3 | 0 |
| Aug 25 | 8 | 152 | 0 | 0 |
| Sep 25 | 9 | 154 | 5 | 0 |
| Oct 25 | 13 | 154 | 6 | 0 |
| Nov 25 | 20 | 139 | 6 | 0 |
| Dec 25 | 17 | 143 | 3 | 0 |
| Jan 26 | 9 | 102 | 5 | 0 |
| Feb 26 | 19 | 116 | 7 | 0 |
| Mar 26 | 16 | 153 | 6 | 0 |
| Apr 26 | 11 | 186 | 5 | 0 |
| May 26 | 24 | 149 | 11 | 0 |
| Jun 26 | 10 | 198 | 17 | 0 |
| Jul 26 | 27 | 176 | 7 | 0 |
| Aug 26 | 12 | 151 | 3 | 2 |
| Sep 26 | 28 | 156 | 6 | 0 |
| Oct 26 | 21 | 163 | 8 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Device Problem Information756
- Device Stenosis352
- Adverse Event Without Identified Device or Use Problem340
- Intravalvular regurgitation330
- Patient Device Interaction Problem241
- Calcified158
- Degraded119
- Perivalvular Leak83
- Incomplete Coaptation73
- Patient-Device Incompatibility64
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information957
- Aortic Valve Insufficiency/ Regurgitation292
- Dyspnea225
- Aortic Valve Stenosis209
- Heart Failure/Congestive Heart Failure200
- No Clinical Signs, Symptoms or Conditions179
- Endocarditis118
- Calcium Deposits/Calcification69
- Hemorrhage/Blood Loss/Bleeding67
- Atrial Fibrillation66
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2984-2020 · Started Jul 29, 2020
Reason given: LivaNova received complaints indicating the impossibility to collapse Perceval valve during procedure. The Dual Collapser is a component of the Perceval single use accessory kits used to reduce the Perceval Sutureless heart valve diameter before valve implant, allowing the Perceval implantation. The issue is relevant...
Cause as FDA categorized it: Nonconforming Material/Component
Z-2985-2020 · Started Jul 29, 2020
Reason given: LivaNova received complaints indicating the impossibility to collapse Perceval valve during procedure. The Dual Collapser is a component of the Perceval single use accessory kits used to reduce the Perceval Sutureless heart valve diameter before valve implant, allowing the Perceval implantation. The issue is relevant...
Cause as FDA categorized it: Nonconforming Material/Component
Z-2986-2020 · Started Jul 29, 2020
Reason given: LivaNova received complaints indicating the impossibility to collapse Perceval valve during procedure. The Dual Collapser is a component of the Perceval single use accessory kits used to reduce the Perceval Sutureless heart valve diameter before valve implant, allowing the Perceval implantation. The issue is relevant...
Cause as FDA categorized it: Nonconforming Material/Component
Z-2987-2020 · Started Jul 29, 2020
Reason given: LivaNova received complaints indicating the impossibility to collapse Perceval valve during procedure. The Dual Collapser is a component of the Perceval single use accessory kits used to reduce the Perceval Sutureless heart valve diameter before valve implant, allowing the Perceval implantation. The issue is relevant...
Cause as FDA categorized it: Nonconforming Material/Component
Z-2988-2020 · Started Jul 29, 2020
Reason given: LivaNova received complaints indicating the impossibility to collapse Perceval valve during procedure. The Dual Collapser is a component of the Perceval single use accessory kits used to reduce the Perceval Sutureless heart valve diameter before valve implant, allowing the Perceval implantation. The issue is relevant...
Cause as FDA categorized it: Nonconforming Material/Component
Z-0716-2017 · Started Oct 31, 2016
Reason given: Sorin Group USA, Inc. announces a voluntary field action for the Perceval Sutureless Heart Valve due to updated steps associated with the implantation procedure.
Cause as FDA categorized it: Use error
Medtronic Cardiovascular Surgery-the Heart Valve Division
Z-0908-2014 · Started Jan 9, 2014 · Posted by FDA Feb 3, 2014
Reason given: Medtronic, Inc. initiated a recall of Medtronic Mosaic Aortic Obturator Model 7305 used with the Mosaic Porcine Aortic Bioprosthesis, Model Number 305, because of higher-than-expected transvalvular gradients occurring post implant.
Cause as FDA categorized it: Device Design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.